Dahua Jixian: Upgrades NXC Bio (01316.HK) rating to "buy" with target price raised significantly to 10 Hong Kong dollars.

According to the Wisdom Financial APP, Dahua Jixian released a research report stating that Net profit of Nissin (01316.HK) in the first half of the year exceeded the bank's expectations, reaching approximately 63 million US dollars (an increase of 305% year on year and a 40% increase in half year). The reason for the higher-than-expected profit is the expansion of profit margin. In the first half of 2025, the gross profit margin increased by 1.5 percentage points year on year, and by 0.6 percentage points in half a year to 11.5%, driven by cost optimization measures, manufacturing efficiency improvement, and restructuring. Based on the higher profit margin, Dahua Jixian raised the company's net profit forecast from 107 million, 125 million, and 146 million US dollars in 2025 to 141 million, 164 million, and 193 million US dollars respectively for 2025-2027. The rating has been upgraded from "hold" to "buy", with the target price increasing significantly from 5 Hong Kong dollars to 10 Hong Kong dollars.